| 1 | Beneficial consequences of probiotic on mitochondrial hippocampus in Alzheimer’s disease. 2021;18:761 doi: 10.1515/jcim-2020-0156 |
| 2 | Polymer drug conjugates containing memantine, tacrine and cinnamic acid: promising nanotherapeutics for the treatment of Alzheimer’s disease. 2023;1 doi: 10.1080/02652048.2023.2167011 |
| 3 | Cranial manipulation affects cholinergic pathway gene expression in aged rats. 2022;122:95 doi: 10.1515/jom-2021-0183 |
| 4 | Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease. 2017;7: doi: 10.1038/s41598-017-09780-3 |
| 5 | Mono- or di-substituted imidazole derivatives for inhibition of acetylcholine and butyrylcholine esterases. 2019;86:187 doi: 10.1016/j.bioorg.2019.01.044 |
| 6 | Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer’s disease treatment. 2018;272:448 doi: 10.1016/j.snb.2018.06.010 |
| 7 | Inhibitory Effects of Raw-Extract Centella asiatica (RECA) on Acetylcholinesterase, Inflammations, and Oxidative Stress Activities via In Vitro and In Vivo. 2020;25:892 doi: 10.3390/molecules25040892 |
| 8 | Rosmarinus officinalis Essential Oil Improves Scopolamine-Induced Neurobehavioral Changes via Restoration of Cholinergic Function and Brain Antioxidant Status in Zebrafish (Danio rerio). 2020;9:62 doi: 10.3390/antiox9010062 |
| 9 | Drug Distribution in Brain and Cerebrospinal Fluids in Relation to IC50 Values in Aging and Alzheimer’s Disease, Using the Physiologically Based LeiCNS-PK3.0 Model. 2022;39:1303 doi: 10.1007/s11095-022-03281-3 |
| 10 | Vital Role of Monoamine Oxidases and Cholinesterases in Central Nervous System Drug Research: A Sharp Dissection of the Pathophysiology. 2020;23:877 doi: 10.2174/1386207323666200220115154 |
Neuroimmunology and Neuroinflammation
